Aclarion Inc. announced the expansion of its multi-center Clinical Utility and Economic (CLUE) Trial to New Jersey. Dr. Justin Kubeck, an orthopedic spine surgeon and founder of Ocean Pain and Spine in Toms River, will initiate the trial in the state. The CLUE Trial aims to assess how often Nociscan’s AI-generated data alters the treatment…
Annual Membership Required
You must be a Annual member to access this content.
Already a member? Log in here